Navigation Links
Blood cholesterol levels predict risk of heart disease due to hormone therapy
Date:5/23/2008

A new analysis of a subgroup of participants in the Womens Health Initiative (WHI) hormone therapy clinical trials suggests that healthy, postmenopausal women whose blood cholesterol levels are normal or lower are not at increased, short-term risk for heart attack when taking hormone therapy. In particular, postmenopausal women who had no history of heart disease but whose ratio of low-density lipoprotein (LDL or bad) cholesterol to high-density lipoprotein (HDL, or good) cholesterol was less than 2.5 were at no increased risk of heart attack or death due to heart attack from taking estrogen plus progestin or estrogen alone, compared to their peers who did not take hormone therapy, after four years of follow up.

Usefulness of Baseline Lipids and C-Reactive Protein in Women Receiving Menopausal Hormone Therapy as Predictors of Treatment-Related Coronary Events, will be published in the June 1 issue of the American Journal of Cardiology. The study was funded by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health.

Michael S. Lauer, M.D., director of the NHLBI Division of Prevention and Population Sciences, is available to comment on this latest analysis of the WHI hormone therapy clinical trials. He emphasizes that the primary results of the WHI hormone therapy clinical trials indicate that, overall, neither form of hormone therapy reduces the risk of heart disease in healthy, postmenopausal women, and estrogen plus progestin increases a womens risk of heart disease. In addition, both estrogen plus progestin and estrogen alone increase the risk of stroke and blood clots serious cardiovascular conditions that the new analysis does not address. Combination hormone therapy also increases the risk of breast cancer.

Identifying which women are more likely to be at increased risk for heart attack when taking hormone therapy can help women and their clinicians make better informed decisions about whether the benefits of hormone therapy outweigh the risks.

In general, however, women should not take hormone therapy to prevent heart disease, and women who choose to use hormone therapy for menopausal symptoms should use the lowest possible dose for the shortest duration. In addition, all women whose blood cholesterol levels are elevated are at increased risk of heart disease, regardless of whether they use hormone therapy, and they should take steps to lower their risk. Heart disease is the leading cause of death among both women and men in the United States.


'/>"/>

Contact: NHLBI Communications Office
NHLBI_news@nhlbi.nih.gov
301-496-4236
NIH/National Heart, Lung and Blood Institute
Source:Eurekalert

Related medicine news :

1. Reducing blockage fails to improve access to the bloodstream for kidney dialysis
2. Home Blood-Pressure Monitoring Recommended
3. Cord Blood America Reports First Quarter Financial Results; Gross Profits Increase
4. Teen Blood Donors More Prone to Complications
5. Study: Doctors Not Always Sure When to Treat Blood Pressure in People With Diabetes
6. Many Diabetics Dont Get Necessary Blood Pressure Treatment
7. Blood-clotting protein modified for people with hard-to-treat hemophilia
8. Blood test for lung cancer may be possible
9. Calpis AmealPeptide lowers blood pressure in 2 placebo-controlled trials
10. Researchers expand natural killer cells in cord blood to fight leukemia
11. Data from Pooled Analyses Demonstrates Welchol, Combined with Metformin- or Sulfonylurea-Based Therapy, Significantly Lowers Blood Glucose in Adults with Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2016)... ... November 30, 2016 , ... The Fertility Centers of ... a Cigna Infertility Center of Excellence. The Cigna Center of Excellence recognizes participating ... honor to be designated a Cigna Infertility Center of Excellence," said Fertility Centers ...
(Date:11/30/2016)... ... 2016 , ... "I hate when the mixture of saliva and toothpaste runs ... inventor from Bridgewater, N.J. "I thought that there had to be a way to ... the patent-pending DEFLECTOR to prevent saliva and toothpaste from running down the brush handle ...
(Date:11/30/2016)... ... November 30, 2016 , ... Center For Discovery, ... the opening of a new eating disorder treatment center location in Palm Beach ... adults and adolescents, both males and females ages 10 and older with eating ...
(Date:11/30/2016)... MA (PRWEB) , ... November 30, 2016 , ... ... for treating injured workers have been a focus of public policymakers and system ... Compensation Research Institute (WCRI) released its Medical Price Index for Workers’ Compensation, ...
(Date:11/30/2016)... ... November 30, 2016 , ... The Clinical Data Interchange Standards ... Binding Guidance goes into effect next month. Sponsors whose studies start after December ... Standards Catalog. The current FDA Data Standards Catalog specifies the use of CDISC ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... bioLytical Laboratories (das "Unternehmen"), ein Weltführer bei schnellen ... HIV-Selbsttests  in einer Version mit geringeren Kosten einzuführen.  ... ... New: INSTI Self Test! (PRNewsFoto/bioLytical Laboratories) ...      (Photo: http://photos.prnewswire.com/prnh/20161201/444833 ) ...
(Date:11/30/2016)... Research and Markets has announced the addition of the ... report to their offering. ... The cerebrospinal fluid (CSF) acts as ... is circulated though the brain and its ventricles, the spine and the ... the brain changes significantly. As a result, intracranial ...
(Date:11/30/2016)...  Millennium Dental Technologies, Inc. announced that it has again ... of the State of California , County ... California,s Uniform Trade Secrets act, Unfair ... practices which are untrue and misleading, as well as other ... the second time in three years that Millennium found it ...
Breaking Medicine Technology: